ANTI-AP2 ANTIBODIES AND ANTIGEN BINDING AGENTS TO TREAT METABOLIC DISORDERS

This invention is in the area of improved anti-aP2 antibodies and antigen binding agents, and compositions thereof, which target the lipid chaperone aP2/FABP4 (referred to as "aP2") for use in treating disorders such as diabetes, obesity, cardiovascular disease, fatty liver disease, and/or...

Full description

Saved in:
Bibliographic Details
Main Authors ADAMS, Ralph, ENGIN, Feyza, DOYLE, Carl, Brendan, HERVÉ, Karine, Jeannine Madeleine, HOTAMISLIGIL, Gökhan, S, WIDENMAIER, Scott, B, WALES, Shauna, Mhairi, ROBERTS, Elisabeth, Helen, MOORE, Adrian, Richard, BURAK, Mehmet, F, TYSON, Kerry, Louise
Format Patent
LanguageEnglish
French
German
Published 07.03.2018
Subjects
Online AccessGet full text

Cover

Loading…